SCHEMBL13890914

SCHEMBL13890914

O=C(O)c1ccc(CCc2ccccc2)cc1Nc1cncc2ccccc12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4C Q9H3R0 10/20 0.46
▸ KDM6B O15054 7/20 0.46
▸ HDAC6 Q9UBN7 1/20 0.45
▸ KDM4D Q6B0I6 4/20 0.44
▸ EGLN3 Q9H6Z9 1/20 0.44
▸ CDC25B P30305 2/20 0.44
▸ TRPV1 Q8NER1 1/20 0.43
▸ ADRA2A P08913 1/20 0.43
▸ ADRA2B P18089 1/20 0.43
▸ ADRA2C P18825 1/20 0.43
▸ ADRA1A P35348 1/20 0.43
▸ MEN1 O00255 1/20 0.43
▸ RECQL P46063 1/20 0.43
▸ BLM P54132 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ TDP1 Q9NUW8 1/20 0.43
▸ KDM4E B2RXH2 2/20 0.42
▸ KDM4A O75164 1/20 0.42
▸ ASPH Q12797 1/20 0.39
▸ RIOX2 Q8IUF8 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL4218342 0.94 CDC25B (0.42) KDM4CKDM6BHDAC6KDM4DEGLN3
SCHEMBL4210974 0.87 TRPV1 (0.56) KDM4CKDM6BKDM4DEGLN3TRPV1
SCHEMBL4211104 0.85 HDAC6 (0.39) HDAC6CDC25BTRPV1ADRA2AADRA2B
SCHEMBL4218343 0.83 HDAC6 (0.38) KDM4CHDAC6CDC25BTRPV1ADRA2A
Trifluoroacetic Acid SCHEMBL4218730 0.82 TRPV1 (0.51) KDM4CKDM6BTRPV1KDM4E
SCHEMBL4209243 0.81 ACLY (0.49) KDM4CCDC25BADRA2AADRA2BADRA2C
SCHEMBL4223020 0.76 MEN1 (0.63) MEN1RECQLBLMKMT2ATDP1
Trifluoroacetic Acid SCHEMBL4222841 0.76 ACLY (0.45) KDM4CCDC25BADRA2AADRA2BADRA2C
SCHEMBL4215640 0.76 MEN1 (0.52) CDC25BMEN1RECQLBLMKMT2A
SCHEMBL4210958 0.75 TRPV1 (0.50) HDAC6TRPV1MEN1RECQLBLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8327467-B2 Anthranilic acid derivative or salt thereof TOYAMA CHEMICAL CO., LTD. (JP) 2012-12-11 — — US disclosed
US-20090105474-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2009-04-23 — — US disclosed
EP-1860098-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2007-11-28 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090105474-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF MMP13, MMP11, MMP3 KDM4C 1892/4885KDM6B 2594/4885HDAC6 609/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback